m-RNA synthesis services enable researchers to develop tailored nucleic acid therapeutics and vaccines for different diseases. The services help design, optimize, manufacture and deliver mRNA for various pre-clinical and clinical applications. The global m-RNA Synthesis Service Market enables pharmaceutical and biotech companies to accelerate drug development without investing heavily in building in-house manufacturing capabilities.
The global m-RNA Synthesis Service Market is estimated to be valued at US$ 6,438.6 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increase in clinical trials assessing the potential of mRNA-based drugs and vaccines has been a major factor fueling the growth of the m-RNA synthesis service market. Numerous ongoing clinical trials are evaluating mRNA therapies targeting cancer, infectious diseases, genetic disorders and more. For instance, Moderna's Phase 3 clinical trial of its mRNA-based COVID-19 vaccine demonstrated nearly 95% efficacy. With the promising clinical data, mRNA is expected to play a vital role against various diseases going forward. This is likely to increase outsourcing of mRNA synthesis to specialized contract service providers in the coming years.
Segment Analysis
The global m-RNA Synthesis Service market is dominated by the messenger segment as RNA plays a very crucial role as carriers of genetic information for protein synthesis. As m-RNA is more stable than other RNA molecules like rRNA, tRNA and it can encode protein more efficiently so it is more preferred for gene expression, therapeutic purposes etc. This has led to high demand for m-RNA synthesis service which has boosted the messenger segment growth.
Key Takeaways
The Global M-RNA Synthesis Service Market Size is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis related content comprises
North America is currently dominating the m-RNA synthesis service market owing to high investment in research & development for novel drug delivery through mRNA therapeutics. The presence of prominent market players and availability of laboratory facilities for custom mRNA synthesis are also contributing to the regional market growth.
Key players related content comprises
Key players operating in the m-RNA Synthesis Service market are Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company, Creative Biogene, Kaneka Corporation, Danaher, eTheRNA, Biomay AG, ApexBio Technology, RiboPro, F. Hoffmann-La Roche Ltd, System Biosciences, LLC., Aurigene Pharmaceutical Services Ltd., OZ Biosciences, Aldevron and GenScript.
Get more insights on this topic:
https://www.dailyprbulletin.com/mrna-synthesis-service-market-size-forecast/
